The first affected individual was dosed on July 22.

The first affected individual was dosed on July 22, 2014. On 9 January, 2014, Avillion announced it had entered into a special collaborative development contract with Pfizer Inc. If authorized for this indication, Avillion will meet the requirements to receive milestone obligations from Pfizer upon regulatory authorization of the drug malegra nebenwirkungen . Related StoriesResearchers identify brand-new way to greatly help AML individuals avoid a relapseProtein-coding gene defined as tumor suppressor for severe myeloid leukemiaBlocking the creation of CHD4 protein can help increase efficiency of AML treatmentsAvillion intends to enrol around 530 patients in to the BFORE trial at multiple sites in the usa, Europe and Asia.